Why the study?
Does the use of thrombectomy devices during primary percutaneous coronary intervention improve clinical outcomes and myocardial perfusion in patients with ST-elevation myocardial infarction?
Does the use of thrombectomy devices during primary percutaneous coronary intervention improve clinical outcomes and myocardial perfusion in patients with ST-elevation myocardial infarction?
This review critically analyzes the literature on the use of thrombectomy devices during primary percutaneous coronary intervention for STEMI to determine their impact on clinical outcomes.
Thrombectomy in STEMI PCI needs more evidence; leaves open routine adoption and selective use.
Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion modality in patients with ST-elevation myocardial infarction (STEMI). While PPCI is highly effective in achieving epicardial coronary reperfusion, a significant proportion of patients fail to achieve adequate myocardial reperfusion. This is in part due to the distal microembolisation of thrombus and plaque debris during PCI. Recognition of this has led to the development of a number of devices with different mechanisms of action that aim to reduce such distal embolisation and therefore improve end myocardial perfusion. Study results of thrombectomy devices however have been largely inconsistent, especially about clinical outcome data, and several meta-analyses have been carried out as a result. This review aims to critically analyse the literature data on thrombectomy during PPCI, taking into account the most recent studies and the latest meta-analyses looking to see whether thrombectomy use is associated with improved outcomes.
No takes yet. Share an insight, caveat, or question.
Rathod et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: